Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: Possible interaction between serotonin and dopamine

Molecular Brain Research

Volumn 37, Issue 1-2, 1996, Pages 105-115

  Rouillard, Claude ^a,b   Bovetto, Sylvie ^a   Gervais, Julie ^b   Richard, Denis ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

5 HT(1A) receptors; 5 HT2 receptors; 5 HT3 receptors; 6 OHDA; Agonists; Antagonists; C fos; D1 receptors; Dopamine; Immunohistochemistry; Rat; Serotonin; Striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; FENFLURAMINE; METHYSERGIDE; OXIDOPAMINE; PROPRANOLOL; RITANSERIN; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INNERVATION; MALE; NEUROTRANSMISSION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029869092     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(95)00284-Y     Document Type: Article

References (70)

1. Arborelius, L., Chergui, K., Murase, S., Nomikos, G.G., Hook, B.B., Chouvet, G., Hacksell, U. and Svensson, T.H., The 5-HT1A selective ligands; (R)-8-OH-DPAT and (S)-UH-301; differentially affect the activity of midbrain dopamine neurons, Naunyn-Schmiedeberg's Arch. Pharmacol, 347 (1993) 353-362.
2. Baker, G.B. and Greenshaw, A.J., Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system, Cell Mol. Neurobiol., 9 (1989) 1-44.
3. Beer, M.S., Middlemiss, D.N. and McAllister, G., 5-HT1 like receptors: six down and still counting, Trends Pharmacol. Sci., 14 (1993) 228-231.
4. Beer, M.S., Stanton, J.A., Hawkins, L.M. and Middlemiss, D.N., 5-Carboxamidotryptamine-insensitive 5-HT1-like receptors are concentrated in guinea pig but not rat claustrum, Eur. J. Pharmacol., 236 (1993) 167-169.
5. Benloucif, S. and Galloway, M.P., Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis, Eur. J. Pharmacol., 200 (1991) 1-8.
6. Benloucif, S., Keegan, M.J. and Galloway, M.P., Serotonin-facilitated dopamine release in vivo: Pharmacological characterization, J. Pharmacol. Exp. Ther., 265 (1993) 373-377.
7. Bischoff, S., Heinrich, M., Sonntag, J.M. and Krauss, J., The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain (5-HT2) receptors, Eur. J. Pharmacol., 129 (1986) 367-370.
8. Blandina, P., Goldfarb, J., Craddock-Royal, B. and Green, J.P., Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in the striatum, J. Pharmacol. Exp. Ther., 251 (1989) 803-809.
9. 4) receptor positively coupled to adenylate cyclase in adult guinea-pig hippocampal membrane: effect of substituted benzamide derivatives, Mol. Pharmacol., 37 (1990) 408-411.
10. Carlsson, A., The current status of the dopamine hypothesis of schizophrenia, Neuropsychopharmacology, 1 (1988) 179-186.
11. Chen, J., van Praag, H. and Gardner, E.L., Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens, Brain Res., 543 (1991) 354-357.
12. De Belleroche, J.S. and Bradford, H.F., Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: A comparison between the effect of 5-hydroxytryptamine, acetylcholine, and glutamate, J. Neurochem., 35 (1980) 1227-1234.
13. De Simoni, M.G., Dal Toso, G., Fodritto, F., Sokola, A. and Algeri, S., Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences, Brain Res., 411 (1987) 81-88.
14. Donoghue, J.P. and Herkenham, M., Neostriatal projections from individual cortical fields conform to histochemically distinct striatal compartments in the rat, Brain Res., 365 (1986) 397-403.
15. Dragunow, M. and Faull, R.L.M., The use of c-fos, as a metabolic marker in neuronal pathway tracing, J. Neurosci. Methods, 29 (1989) 261-265.
16. Dragunow, M., Robertson, G.S., Faull, R.L.M., Robertson H.A. and Jansen K., D2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons, Neuroscience, 37 (1990) 287-294.
17. Dumuis, A., Bouhelal, R., Sebben, M., Cory, R. and Bockaert, J., A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system, Mol. Pharmacol., 34 (1988) 880-887.
18. Dunnett, S.B. and Iversen, S.D., Learning impairments following selective kainic acid lesions within the neostriatum of rats, Behav. Brain Res., 2 (1981) 189-209.
19. Dunnett, S.B. and Iverson, S.D., Sensorimotor impairments following localized kainic acid and 6-hydroxydopamine lesions of the neostriatum, Brain Res., 248 (1982) 121-127.
20. Eriksson, E. and Humble, M., Serotonin in psychiatric pathophysiology. In: R. Pohl and S. Gershon (Eds.), The Biological Basis of Psychiatric Treatment, Prog. Basic Clin. Pharmacol. Vol. 3, S. Karger, Farmington, CT, 1990, pp. 66-119.
21. Gerfen, C.R., The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination, Science, 246 (1989) 385-388.
22. Gerfen, C.R., The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia, Ann. Rev. Neurosci., 15 (1992) 285-320.
23. Gervais, J., Bovetto, S., Richard, D. and Rouillard, C., Striatal c-fos induction by concomittant stimulation of 5-HT1A-5-HT2, D1-5-HT1A and D1-5-HT2 receptors, Soc. Neurosci. Abstr., 20 (1994) 1551.
24. Gervais, J. and Rouillard, C., Electrophysiological responses of mesencephalic dopamine neurons to dorsal raphe stimulation in 5-HT depleted rats, Soc. Neurosci. Abstr., 19 (1993) 1372.
25. Graybiel, A.M., Moratalla, R. and Robertson, H.A., Amphetamine and cocaine induce drug-specific activition of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum, Proc. Natl. Acad. Sci. USA, 87 (1990) 6912-6916.
26. Graybiel, A.M. and Ragsdale Jr., C.W., Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylcholinesterase staining, Proc. Natl. Acad. Sci. USA, 75 (1978) 5723-5726.
27. Grossman, C.J., Kilpatrick, G.J. and Bunce, K.T., Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain, Br. J. Pharmacol., 109 (1993) 618-624.
28. Hervé, D., Pickel, V.M., Joh, T.H. and Beaudet, A., Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons, Brain Res., 435 (1987) 71-83.
29. Hervé, D., Simon, H., Blanc, G., Lisoprawski, A., Lemoal, M., Glowinski, J. and Tassin, J.P., Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat, Neurosci. Lett., 15 (1979) 127-133.
30. Jiang, L.H., Ashby Jr., C.R., Kasser, R.J. and Wang, R.Y., The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study, Brain Res., 513 (1990) 156-160.
31. Kelland, M.D., Freeman, A.S. and Chiodo, L.A., Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons, J. Pharmacol. Exp. Ther., 253 (1990) 803-811.
32. Lavoie, B. and Parent, A., Immunohistochemical study of the serotonergic innervation of the basal ganglia in the squirrel monkey, J. Comp. Neurol., 299 (1990) 1-16.
33. 2/1c receptor activation causes a localized expression of immediate-early gene c-fos, in rat brain: evidence for involvement of dorsal raphe nucleus projection fibres, Neuroscience, 53 (1993) 457-463.
34. Li, B.H. and Rowland, N.E., Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats, Brain Res. Bull., 31 (1993)43-48.
35. Maroteaux, L., Saudou, F., Amlaiky, N., Boschert, U., Plassat, J.L. and Hen, R., Mouse 5HTIB serotonin receptor: Cloning; functional expression; and localization in motor control centers, Proc. Natl. Acad. Sci. USA, 89 (1992) 3020-3024.
36. McGeorge, A.J. and Faull, R.L.M.K., The organisation of the projection from the cerebral cortex to the striatum in the rat. Neuroscience, 29 (1989) 503-537.
37. Miller, J.C., Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs, J. Neurochem., 54 (1990) 1453-1455.
38. Monsma Jr., F.J., Shen, Y., Ward, R.P., Hamblin, M.W. and Sibley, D.R., Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs, Mol. Pharmacol., 43 (1993) 320-327.
39. Morgan, J.I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun, Annu. Rev. Neurosci., 14 (1991) 421-451.
40. New, J.S., The discovery and development of buspirone: a new approach to the treatment of anxiety, Med. Res. Rev., 10 (1990) 283-286.
41. Ngyuen, T.V., Kosofsky, B.E., Birnbaum, R., Cohen, M.B. and Hyman, S.E., Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine and amphetamine, Proc. Natl. Acad. Sci. USA, 89 (1992) 4270-4274.
42. Palacios, J.M., Waeber, C., Hoyer, D. and Mengod, G., Distribution of serotonin receptors. In: P.M. Whitaker-Amiztia and S.J. Peroutka (Eds.), The Neurophannacology of Serotonin, Annals of the New York Academy of Sciences, Vol. 600, New York, 1990, pp. 36-52.
43. Palfreyman, M.G., Schmidt, C.J., Sorensen, S.M., Dudley, M.W., Kehne, J.H., Moser, P., Gittos, M.W. and Carr, A.A., Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function, Psychopharmacology, 112 (1993) S60-S67.
44. Parent, A., Comparative Neurobiology of the Basal Ganglia, John Wiley & Sons, New York, 1986.
45. Parsons, L.H. and Justice Jr., J.B., Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis, Brain Res., 606 (1993) 195-199.
46. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, 1986.
47. Richard, D., Rivest, S. and Rivier, C., The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain, Brain Res., 594 (1992) 131-137.
48. Robertson, G.S. and Fibiger, H.C., Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience, 46 (1992) 315-328.
49. Robertson, G.S., Herrera, D.G., Dragunow, M. and Robertson, H.A., L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra, Eur. J. Pharmacol., 159 (1989) 99-100.
50. Robertson, H.A., Peterson, M.R., Murphy, K. and Robertson, G.S., D-1 dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour, Brain Res., 503 (1989) 346-349.
51. Robertson, L.M., Kerppola, T.K., Vendrell, M., Luk, D., Smeyne, R.J., Bocchiaro, C., Morgan, J.I. and Curran, T., Regulation of c-fos expression in transgenic mice requires multiple interdependant transcription control elements, Neuron, 14 (1995) 241-252.
52. Rouillard, C. and Gervais, J., Electrophysiological responses of mesencephalic dopamine neurons to dorsal raphe stimulation, Soc. Neurosci. Abstr., 18 (1992) 277.
53. 6) receptor: molecular cloning, localization and stimulation of cAMP accumulation, Biochem. Biophys. Res. Commun., 193 (1993) 268-276.
54. 2 dopamine receptor activation, Synapse, 18 (1994) 233-240.
55. Sagar, S.M., Sharp, F.R. and Curran, T., Expression of c-fos protein in brain: metabolic mapping at the cellular level, Science, 240 (1988) 1328-1331.
56. Seeman, P., Dopamine receptors and the dopamine hypothesis of schizophrenia, Synapse, 1 (1987) 133-152.
57. Seeman, P. and Niznik, H.B., Dopamine receptors and transporters in Parkinson's disease and schizophrenia, Fed. Proc. Fed. Am. Soc. Exp. Biol., 4 (1990) 2737-2744.
58. Sharp, F.R., Sagar, S.M., Hicks, K., Lowenstein D. and Hisanaga K., c-Fos mRNA, Fos, and Fos-related antigen induction by hypertonic saline and stress, J. Neurosci., 11 (1991) 2321-2331.
59. Sheng, M. and Greenberg, M.E., The regulation and function of c-fos and other immediate early genes in the nervous system, Neuron, 4 (1990) 477-485.
60. Soghomonian, J.-J. and Chesselet, M.-F., Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum; the entopedoncular nucleus and the lateral hypothalamus of the rat, Neuroscience. 42 (1991) 49-59.
61. Soghomonian, J.-J., Gonzales, C. and Chesselet, M.-F., Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons, Brain Res., 576 (1992) 68-79.
62. Sonnenberg, J.L., Rauscher III, F.J., Morgan, J.I. and Curran, T., Regulation of proenkephalin by Fos and Jun, Science, 246 (1989) 1622-1625.
63. Sorenson, S.M., Humphreys, T.M. and Palfreyman, M.G., Effect of acute and chronic MDL 73, 147EF, a 5-HT3 receptor antagonist, on A9 and A1O dopamine neurons, Eur. J. Pharmacol., 163 (1989) 115-118.
64. Steinbusch, H.W.M., Niewenhuys, R., Verhofstad, A.A.J. and Van der Kooy, D., The nucleus raphe dorsalis of the rat and its projection upon the caudate-putamen. A combined cytoarchitectonic immunocytochemical and retrograde transport study, J. Physiol, 11 (1981) 157-174.
65. Torres, G. and Rivier, C., Regional effects of NMDA receptor antagonists on the induction of striatal c-fos by fenfluramine, Mol. Cell. Neurosci., 4 (1993) 231-236.
66. Torres, G. and Rivier, C., Induction of c-fos in rat brain by acute cocaine and fenfluramine exposure: A comparison study, Brain Res., 647 (1994) 1-9.
67. Ugedo, L., Grenhoff, J. and Svensson, T.H., Ritanserin; a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition, Psychopharmacology, 98 (1989) 45-50.
68. Van der Kooy. D. and Hattori, D., Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: A fluorescent retrograde double labeling study in the rat. Brain Res., 186 (1980) 1-7.
69. Walters, E.T. and Ambron, R.T., Long-term alterations induced by injury and by 5-HT in Aplysia sensory neurons: convergent pathways and common signals? Trends Neurosci., 18 (1995) 137-142.
70. Young, S.T., Porrino, L.J. and Iadarola, M.J., Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D-1 receptors, Proc. Natl. Acad. Sci. USA, 88 (1991) 1291-1295.